This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Marsh & McLennan Companies Announces Pricing Of $500 Million Senior Notes Offering

Marsh & McLennan Companies, Inc. (the “Company”) announced today that it has priced $250 million of 2.55% senior notes due 2018 and $250 million of 4.05% senior notes due 2023 (collectively, the “Notes”). The Company intends to use the net proceeds for general corporate purposes, which will include the redemption of $250 million of the outstanding principal amount of its existing 5.75% senior notes due September 2015. The closing of the Notes offering is expected to occur on September 27, 2013, subject to certain customary conditions. Goldman, Sachs & Co., HSBC, BofA Merrill Lynch and Deutsche Bank Securities are acting as joint book-running managers for the offering. Barclays, Citigroup, J.P. Morgan and Morgan Stanley are acting as co-managers for the offering.

An effective shelf registration statement related to the Notes has previously been filed with the Securities and Exchange Commission. The offering and sale of the Notes are being made by means of a prospectus supplement and an accompanying base prospectus related to the offering, copies of which may be obtained from: (i) Goldman, Sachs & Co., Attention: Prospectus Department, 200 West Street, New York, New York 10282, telephone: 1-866-471-2526, facsimile: 1-212-902-9316 or email: prospectus-ny@ny.email.gs.com, (ii) HSBC Securities (USA) Inc., by phone (toll free): 1-866-811-8049, (iii) Merrill Lynch, Pierce, Fenner & Smith Incorporated at 222 Broadway, New York NY 10038, Attention: Prospectus Department or by email at dg.prospectus_requests@baml.com or by telephone at 1-800-294-1322 and (iv) Deutsche Bank Securities Inc. at 60 Wall Street, New York, New York 10005, Attention: Prospectus Group or by telephone at 800-503-4611 or by email at prospectus.cpdg@db.com.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor does it constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,596.35 -350.33 -1.95%
S&P 500 2,057.64 -43.85 -2.09%
NASDAQ 4,958.4680 -122.0370 -2.40%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs